Cambridge Nutritional SciencesFRA:RVKA +3.70% EV-to-FCF is -1.11 as of Jul. 03, 2026. The stock has 3 warning signs investors should review. Among 418 Medical Devices & Instruments companies, Cambridge Nutritional Sciences ranks worse than 239234.21% on this metric.
The historical rank and industry rank for Cambridge Nutritional Sciences's EV-to-FCF or its related term are showing as below:
FRA:RVKA'
s EV-to-FCF Range Over the Past 10 Years
Min: -96.27 Med: -5.12 Max: 9.24
Current: -1.07
During the past 13 years, the highest EV-to-FCF of Cambridge Nutritional Sciences was 9.24. The lowest was -96.27. And the median was -5.12.
FRA:RVKA's EV-to-FCF is ranked worse than 100% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 23.12
vs FRA:RVKA: -1.07
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cambridge Nutritional Sciences's PE Ratio (TTM) for today is calculated as:
Cambridge Nutritional Sciences's share price for today is €0.014.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cambridge Nutritional Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was €0.008.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Cambridge Nutritional Sciences EV-to-FCF Related Terms
Cambridge Nutritional Sciences EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cambridge Nutritional Sciences EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Cambridge Nutritional Sciences's EV-to-FCF falls into.
Cambridge Nutritional Sciences's current Enterprise Value is €0.94 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cambridge Nutritional Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was €-0.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Nutritional Sciences (FRA:RVKA) has a EV-to-FCF of -1.11 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cambridge Nutritional Sciences and its competitors. According to the industry distribution chart, Cambridge Nutritional Sciences ranks #999999 out of 418 companies in the Medical Devices & Instruments industry.
Is Cambridge Nutritional Sciences' EV-to-FCF too high?
Cambridge Nutritional Sciences' current EV-to-FCF is -1.11. Based on the distribution chart, Cambridge Nutritional Sciences ranks #999999 out of 418 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Cambridge Nutritional Sciences' EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Cambridge Nutritional Sciences ranks #999999 out of 418 companies for EV-to-FCF. This places Cambridge Nutritional Sciences in the lower half of its industry. The industry median EV-to-FCF is 23.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.12, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cambridge Nutritional Sciences and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cambridge Nutritional Sciences's current EV-to-FCF is -1.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Cambridge Nutritional Sciences (FRA:RVKA) has a current EV-to-FCF of -1.11. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 30% below its estimated fair value. The current EV-to-FCF is -1.11. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Cambridge Nutritional Sciences (FRA:RVKA), the current EV-to-FCF is -1.11 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cambridge Nutritional Sciences Business Description
Cambridge Nutritional Sciences PLC is a medical diagnostics company specializing in the development, manufacture, and distribution of food sensitivity test kits. Its product portfolio includes tests designed to detect immune reactions to various foods, helping healthcare professionals and patients identify dietary and lifestyle changes to improve long-term health and wellbeing. The company operates in the United Kingdom and serves the customer base across various countries through laboratories and healthcare providers. It generates revenue by selling diagnostic kits and providing clinical analysis services centered on food sensitivity and gut health. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition segment generates majority revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RVKA has been successfully added to your 